Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023;73:17-48. doi: 10.3322/caac.21763.

Zhao F, Wu T, Wang LM, et al. Survival and prognostic factors of adult intracranial ependymoma: a single-institutional analysis of 236 patients. Am J Surg Pathol 2021;45:979-87. doi:10.1097/PAS.0000000000001669.

Garcia MR, Feng Y, Vasudevaraja V, et al.. Clinical, pathological, and molecular characteristics of diffuse spinal cord gliomas. J Neuropathol Exp Neurol 2022;81:865-72. doi: 10.1093/jnen/nlac075.

Lamba N, Groves A, Torre M, Yeo KK, Iorgulescu JB. The epidemiology of primary and metastatic brain tumors in infancy through childhood. Neuro Oncol 2022;156:419-29. doi: 10.1007/s11060-021-03927-z.

Johnson DR, Guerin JB, Giannini C, Morris JM, Eckel LJ, Kaufmann TJ. 2016 updates to the WHO brain tumor classification system: what the radiologist needs to know. Radiographics 2017;37:2164-80.doi: 10.1148/rg.2017170037.

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of tumors of the central nervous system: a summary. Neuro Oncol 2021;23:1231–51. doi: 10.1093/neuonc/noab106.

Miller KD, Ostrom QT, Kruchko C, et al. Brain and other central nervous system tumor statistics, 2021. CA CANCER J CLIN 2021;71:381-406. doi: 10.3322/caac.21693.

Ostrom QT, Francis SS, Barnholtz-Sloan JS. Epidemiology of brain and other CNS tumors. Curr Neurol Neurosci Rep 2021;21:68. doi: 10.1007/s11910-021-01152-9.

Soon WC, Goacher E, Solanki S, et al. The role of sex genotype in paediatric CNS tumour incidence and survival. Childs Nerv Syst 2021;37:2177-86. doi: 10.1007/s00381-021-05165-0.

Salehpour F, Mirzaei F, Meshkini A, Parsay S, Salehi S, Asl MM. Trends in primary brain tumors: a 5-year retrospective histologically confirmed study in Tabriz, Iran, 2011–2016. Asian J Neurosurg 2019;14:427-31. doi: 10.4103/ajns.AJNS_212_18.

Tolou-Ghamari, Z. Preliminary study of central nervous system tumors’ prevalence and incidence in Isfahan Province Iran. J Egypt Natl Canc Inst 2020;32:14. doi:10.1186/s43046-020-00022-8.

de Robles P, Fiest KM, Frolkis AD, et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol 2015;17:776-83.doi: 10.1093/neuonc/nou283.

World Health Organization. International classification of diseases for oncology (ICD-O). 3rd ed., 1st revision. Geneva: World Health Organization;2013.

Dho YS, Jung KW, Ha J, et al. An updated nationwide epidemiology of primary brain tumors in Republic of Korea, 2013. Brain Tumor Res Treat 2017; 5:16-23. doi: 10.14791/btrt.2017.5.1.16.

Mehrvar A, Faranoush M, Hedayati Asl AA,et al. Childhood central nervous system tumors at MAHAK’s Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran. Childs Nerv Syst 2014;30:491-6. doi: 10.1007/s00381-013-2256-8.

Garcia CR, Slone SA, Dolecek TA, Huang B, Neltner JH, Villano JL. Primary central nervous system tumor treatment and survival in the United States, 2004–2015. J Neurooncol 2019;144:179-91.doi: 10.1007/s11060-019-03218-8.

Araghi M, Roshandel G, Hasanpour-Heidari S, et al. Incidence of malignant brain and central nervous system tumors in Golestan, Iran, 2004-2013. Arch Iran Med 2020;23:1-6.

Jazayeri SB, Rahimi-Movaghar V, Shokraneh F, Saadat S, Ramezani R. Epidemiology of primary CNS tumors in Iran: a systematic review. Asian Pac J Cancer Prev 2013;14:3979-85. doi: 10.7314/apjcp.2013.14.6.3979.

Beygi S, Saadat S, Jazayeri SB, Rahimi-Movaghar V. Epidemiology of pediatric primary malignant central nervous system tumors in Iran: a 10 year report of National Cancer Registry. Cancer Epidemiol 2013;37:396-401.doi: 10.1016/j.canep.2013.03.002.

Boschetti G, Santos AJ, Fermon KP, et al. Adult pilocytic astrocytomas: a Brazilian series. World Neurosurg 2020;133:e115-e20. doi: 10.1016/j.wneu.2019.08.146.

Ostrom QT, Cioffi G, Gittleman H, et a.. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol 2019;21(Suppl 5):v1-v100. doi: 10.1093/neuonc/noz150.

Zahir ST, Vakili M, Navabii H, Rahmani K. Clinicopathological findings and five year survival rates for patients with central nervous system tumors in Yazd, Iran. Asian Pac J Cancer Prev 2014;15:10319-23. doi: 10.7314/apjcp.2014.15.23.10319.

Huang Q, Li F, Chen Y, Hong F, Wang H, Chen J. Prognostic factors and clinical outcomes in adult primary gliosarcoma patients: a Surveillance, Epidemiology, and End Results (SEER) analysis from 2004 to 2015. Br J Neurosurg 2020:34:161-7. doi: 10.1080/02688697.2019.1699903.